This was in the AGM announcement, Take particular note of the LAST SENTENECE.
"on 19 July 2017 MCL, through its Director Andrew Kavasilas, applied to the Australian Government for a research cultivation licence, which is required prior to making an application for a permit to operate under that licence to grow cannabis varieties for medical cannabis research for the purposes of product development. As at the date of this Notice, the above permit has not been granted (and therefore the milestone relating to the conversion of the Performance Shares, as set out in paragraph (l) of Schedule 1 of this Notice, has not been achieved). From recent discussions with the Office of Drug Control, it is anticipated that, all things being equal, the grant of the permit will occur by October 2017."
- Forums
- ASX - By Stock
- CGB
- Ann: Approval of Environmental Authority for the MDL Work Program
Ann: Approval of Environmental Authority for the MDL Work Program, page-45
-
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online